S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
BVS · Bioventus Inc. Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$14.25
+0.32
(+2.30%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$14.25
$13.93
$14.27
52-WEEK RANGE
$14.25
$6.47
$15.89
What's happening
- BVS is up 2.30% today, trading at $14.25. — Live quote
- Volume today (30,412) is well below its 3-month average of 617,680. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.22 actual vs. $0.22 estimated (+0.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 6
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
BVS
+87.50%
vs S&P 500
+74.72%
1-YEAR RETURN
BVS
+99.29%
vs S&P 500
+84.72%
6-MONTH RETURN
BVS
+34.01%
3-MONTH RETURN
BVS
+17.42%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.22
Est. $0.22
BEAT +0.8%
2026-04-26 (Q1 2026)
$0.15
Est. $0.10
BEAT +52.3%
2026-01-26 (Q4 2025)
$0.24
Est. $0.22
BEAT +9.7%
2025-10-26 (Q3 2025)
$0.15
Est. $0.12
BEAT +29.1%
Valuation Measures & Ratios
Enterprise Value4$1.40B
Forward P/E515.59
PEG Ratio61.76
Price / Sales (TTM1)2.02
Price / Book72.90
EV4 / Revenue2.41
EV4 / EBITDA22.31
Profit Margin9.36%
Operating Margin9.96%
Return on Equity (ROE8)28.39%
Return on Assets (ROA9)8.04%
Avg Volume (3M)617,680
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $693.0M | $696.1M | $420.2M | $457.7M | $594.6M |
| P/E | 14.69 | 62.77 | 149.45 | -17.59 | -15.50 |
| Price/Sales | 1.21 | 1.28 | 0.77 | 0.81 | 1.09 |
| Price/Book | 3.04 | 3.69 | 2.53 | 2.84 | 4.01 |
| EV/Revenue | 1.60 | 1.72 | 1.28 | 1.36 | 1.69 |
| EV/EBITDA | 8.87 | 10.43 | — | — | — |
| ROE | 20.66% | 5.87% | 1.69% | -16.14% | -25.90% |
| ROA | 7.01% | 1.70% | 0.40% | -3.68% | -5.55% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short3,161,332
Change from Prior Settlement+7.87%
% of Float—
Days to Cover (Short Ratio)6.70
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 3.8% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +99.3%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 9.4%. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-08-05; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on BVS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $153.2M | $132.1M | $138.7M | $147.7M | $123.9M | $139.0M | $151.2M | $129.5M |
| Gross profit | $105.7M | $90.8M | $94.2M | $102.1M | $83.1M | $93.6M | $103.6M | $88.4M |
| Operating income | $19.1M | $8.4M | $11.3M | $18.4M | $4.9M | $3.6M | -$31.5M | $4.9M |
| Net income | $33.4M | $3.1M | $3.2M | $7.5M | -$2.6M | -$5.2M | -$25.7M | -$4.9M |
| EPS (diluted) | $0.47 | $0.04 | $0.05 | $0.11 | $-0.04 | $-0.08 | $-0.40 | $-0.08 |
| EPS (basic) | $0.49 | $0.05 | $0.05 | $0.11 | $-0.04 | $-0.08 | $-0.40 | $-0.08 |
| Operating margin | $12 | $6 | $8 | $12 | $4 | $3 | -$21 | $4 |
| Net margin | $22 | $2 | $2 | $5 | -$2 | -$4 | -$17 | -$4 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $673.3M | $650.5M | $683.6M | $701.6M | $706.8M | $691.4M | $728.0M | $769.5M |
| Total liabilities | $395.9M | $416.3M | $455.1M | $494.3M | $505.5M | $505.9M | $542.4M | $582.7M |
| Stockholders' equity | $228.3M | $188.9M | $184.1M | $166.1M | $161.2M | $148.1M | $147.9M | $148.7M |
| Total current assets | $257.5M | $249.8M | $272.8M | $280.9M | $275.2M | $249.4M | $275.6M | $298.7M |
| Total current liabilities | $152.5M | $148.1M | $160.4M | $161.8M | $185.7M | $174.8M | $210.4M | $211.5M |
| Cash & equivalents | $29.5M | $35.8M | $51.2M | $42.2M | $32.9M | $22.8M | $41.6M | $43.1M |
| Accounts receivable | $138.4M | $120.5M | $128.3M | $130.4M | $132.4M | $118.1M | $127.4M | $121.9M |
| Inventory | $79.8M | $83.2M | $82.2M | $96.3M | $96.5M | $94.0M | $92.5M | $90.0M |
| Marketable securities (non-current) | $3.5M | $2.1M | $2.3M | $2.3M | $1.7M | $1.8M | $1.9M | $1.9M |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Goodwill | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M |
| Intangible assets | $351.0M | $359.7M | $368.4M | $377.4M | $387.0M | $395.7M | $404.7M | $414.8M |
| Accounts payable | $20.2M | $24.1M | $10.9M | $26.6M | $24.2M | $19.2M | $23.7M | $16.8M |
| Accrued liabilities | $109.4M | $101.1M | $130.2M | $119.4M | $113.7M | $103.3M | $135.9M | $128.7M |
| Deferred revenue (current) | — | — | $955.0K | — | — | — | $1.7M | — |
| Short-term debt | $18.8M | $18.8M | $15.0M | $11.2M | $43.4M | $37.3M | $27.3M | $38.6M |
| Other current liabilities | $4.1M | $4.2M | $4.2M | $4.4M | $4.4M | $4.4M | $3.9M | $3.9M |
| Long-term debt | $229.7M | $253.3M | $279.0M | $311.3M | $297.9M | $308.6M | $308.3M | $345.0M |
| Other non-current liabilities | $13.2M | $14.3M | $15.3M | $20.5M | $21.3M | $22.0M | $23.1M | $26.1M |
| Retained earnings | -$298.4M | -$331.8M | -$334.9M | -$349.7M | -$352.8M | -$360.3M | -$357.7M | -$354.9M |
| Accumulated other comprehensive income (loss) | -$1.3M | -$2.3M | -$1.9M | -$1.8M | -$774.0K | -$2.1M | -$2.6M | $445.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Nov '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.9M | $8.9M | $38.0M | $30.1M | $25.9M | -$19.3M | $19.3M | — |
| Investing cash flow | -$2.5M | -$574.0K | -$580.0K | -$473.0K | -$1.4M | -$826.0K | $24.1M | — |
| Financing cash flow | -$23.4M | -$23.1M | -$28.4M | -$20.0M | -$14.7M | $947.0K | -$42.9M | — |
| Free cash flow | $18.9M | $8.4M | $37.4M | $29.6M | $25.3M | -$20.2M | $18.7M | — |
| Capital expenditures | $960.0K | $574.0K | $580.0K | $473.0K | $683.0K | $826.0K | $574.0K | — |
| Depreciation & amortization | $10.9M | $11.2M | $11.7M | $11.4M | $12.0M | $11.9M | $12.4M | — |
| Share-based compensation | $5.0M | $3.3M | $3.4M | $3.2M | $3.6M | $2.4M | $2.0M | — |
| Deferred income taxes | — | — | -$909.0K | — | — | — | -$5.4M | — |
| Change in accounts receivable | $17.9M | -$7.3M | -$1.9M | -$1.8M | $13.6M | -$9.0M | $5.8M | — |
| Change in inventory | -$3.0M | $2.6M | -$13.0M | -$291.0K | $2.8M | $1.9M | $5.6M | — |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | — | — | — | — | — | — | $0 | — |
| Debt repaid | — | — | — | — | — | — | — | $5.0M |
| Tax withholding on stock comp | $294.0K | $1.0M | $0 | $9.0K | $0 | $0 | $0 | — |
| Other financing activities | -$241.0K | -$220.0K | -$208.0K | -$207.0K | -$209.0K | -$203.0K | -$194.0K | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $568.1M | $573.3M | $512.3M | $512.1M | $430.9M |
| Gross profit | $388.2M | $388.2M | $328.2M | $331.1M | $302.7M |
| Operating income | $54.0M | -$15.2M | -$81.7M | -$167.2M | $12.1M |
| Net income | $22.7M | -$36.1M | -$156.2M | -$158.7M | $19.4M |
| EPS (diluted) | $0.33 | $-0.56 | $-2.49 | $-2.59 | $-0.15 |
| EPS (basic) | $0.34 | $-0.56 | $-2.49 | $-2.59 | $-0.15 |
| Operating margin | $10 | -$3 | -$16 | -$33 | $3 |
| Net margin | $4 | -$6 | -$30 | -$31 | $4 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $683.6M | $728.0M | $810.9M | $1.37B | $1.23B |
| Total liabilities | $455.1M | $542.4M | $589.8M | $960.4M | $618.2M |
| Stockholders' equity | $184.1M | $147.9M | $173.6M | $325.2M | $458.9M |
| Total current assets | $272.8M | $275.6M | $268.0M | $272.6M | $263.1M |
| Total current liabilities | $160.4M | $210.4M | $175.5M | $304.0M | $180.9M |
| Cash & equivalents | $51.2M | $41.6M | $37.0M | $30.2M | $43.9M |
| Accounts receivable | $128.3M | $127.4M | $122.8M | $136.3M | $125.0M |
| Inventory | $82.2M | $92.5M | $91.3M | $84.8M | $61.7M |
| Marketable securities (non-current) | $2.3M | $1.9M | $3.1M | $2.6M | $29.3M |
| Property, plant & equipment | — | — | — | $27.6M | $23.0M |
| Goodwill | $7.5M | $7.5M | $7.5M | $7.5M | $147.6M |
| Intangible assets | $368.4M | $404.7M | $482.4M | $639.9M | $695.2M |
| Accounts payable | $10.9M | $23.7M | $23.0M | $36.7M | $16.9M |
| Accrued liabilities | $130.2M | $135.9M | $119.8M | $111.6M | $131.5M |
| Deferred revenue (current) | $955.0K | $1.7M | $2.3M | $2.9M | $2.4M |
| Short-term debt | $15.0M | $27.3M | $27.8M | $33.1M | $18.0M |
| Other current liabilities | $4.2M | $3.9M | $4.8M | $3.6M | $3.6M |
| Long-term debt | $279.0M | $308.3M | $367.0M | $385.0M | $339.6M |
| Other non-current liabilities | $15.3M | $23.1M | $27.9M | $22.8M | $21.7M |
| Retained earnings | -$334.9M | -$357.7M | -$321.5M | -$165.3M | -$6.6M |
| Accumulated other comprehensive income (loss) | -$1.9M | -$2.6M | $794.0K | -$110.0K | $179.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $74.7M | $38.8M | $15.3M | -$13.5M | $23.0M |
| Investing cash flow | -$3.2M | $23.0M | $15.8M | -$116.4M | -$283.8M |
| Financing cash flow | -$62.1M | -$54.6M | -$26.7M | $62.1M | $273.4M |
| Free cash flow | $72.1M | $37.8M | $8.0M | -$15.0M | $9.5M |
| Capital expenditures | $2.6M | $1.0M | $7.4M | $1.5M | $13.5M |
| Depreciation & amortization | $47.0M | $49.6M | $57.4M | $55.4M | $34.9M |
| Share-based compensation | $12.7M | $13.3M | $2.7M | $17.6M | $19.8M |
| Deferred income taxes | -$909.0K | -$5.4M | -$2.4M | -$46.7M | -$9.8M |
| Change in accounts receivable | $916.0K | $10.7M | -$10.1M | $17.7M | $20.1M |
| Change in inventory | -$8.6M | $16.4M | $6.0M | $18.6M | -$3.2M |
| Purchases of investments | — | — | — | — | $13.5M |
| Other investing activities | — | $0 | $0 | $75.0K | $0 |
| Tax withholding on stock comp | $9.0K | $0 | $0 | $3.4M | $0 |
| Other financing activities | -$827.0K | -$758.0K | -$506.0K | -$15.0K | -$404.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding BVS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-11-07 to 2026-06-02
Recent transactions
- Most recent: Bartholdson John A. (Director) — Option exercise of 32,282 shares on 2026-06-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Bartholdson John A. | Director | Option exercise | 2026-06-02 | 32,282 |
| SUTTER MARTIN P | Director | Option exercise | 2026-06-02 | 32,282 |
| STALNECKER SUSAN M | Director | Option exercise | 2026-06-02 | 32,282 |
| NOHRA GUY P | Director | Option exercise | 2026-06-02 | 32,282 |
| NEELS GUIDO J | Director | Option exercise | 2026-06-02 | 32,282 |
| McMurry-Heath Michelle | Director | Option exercise | 2026-06-02 | 32,282 |
| Ladone Mary Kay | Director | Option exercise | 2026-06-02 | 32,282 |
| HAWKINS WILLIAM A | Director | Option exercise | 2026-06-02 | 39,789 |
| Cowdy Philip G. | Director | Option exercise | 2026-06-02 | 32,282 |
| Beyer Pat | Director | Option exercise | 2026-06-02 | 32,282 |
| Singleton Mark Leonard | SVP & CFO | Option exercise | 2026-04-10 | 13,000 |
| CHURCH KATRINA J | SVP & Chief Compliance Officer | Option exercise | 2026-04-10 | 4,300 |
| D'Adamio Anthony | SVP & General Counsel | Option exercise | 2026-04-10 | 9,925 |
| Claypoole Robert E | President and CEO | Option exercise | 2026-03-13 | 33,500 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-02 | Bartholdson John A. | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | SUTTER MARTIN P | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | STALNECKER SUSAN M | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | NOHRA GUY P | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | NEELS GUIDO J | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | McMurry-Heath Michelle | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | Ladone Mary Kay | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | HAWKINS WILLIAM A | Director | Option exercise | 39,789 | $0.00 |
| 2026-06-02 | Cowdy Philip G. | Director | Option exercise | 32,282 | $0.00 |
| 2026-06-02 | Beyer Pat | Director | Option exercise | 32,282 | $0.00 |
| 2026-04-10 | Singleton Mark Leonard | SVP & CFO | Option exercise | 13,000 | $0.00 |
| 2026-04-10 | Singleton Mark Leonard | SVP & CFO | Tax withholding | 5,648 | $9.06 |
| 2026-04-10 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Option exercise | 4,300 | $0.00 |
| 2026-04-10 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Tax withholding | 1,868 | $9.06 |
| 2026-04-10 | D'Adamio Anthony | SVP & General Counsel | Option exercise | 9,925 | $0.00 |
| 2026-04-10 | D'Adamio Anthony | SVP & General Counsel | Tax withholding | 4,312 | $9.06 |
| 2026-03-20 | Singleton Mark Leonard | SVP & CFO | Option exercise | 18,625 | $0.00 |
| 2026-03-20 | Singleton Mark Leonard | SVP & CFO | Tax withholding | 8,091 | $8.64 |
| 2026-03-13 | Singleton Mark Leonard | SVP & CFO | Option exercise | 13,500 | $0.00 |
| 2026-03-13 | Singleton Mark Leonard | SVP & CFO | Tax withholding | 5,865 | $8.62 |
| 2026-03-13 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Option exercise | 3,455 | $0.00 |
| 2026-03-13 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Tax withholding | 1,501 | $8.62 |
| 2026-03-13 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Option exercise | 3,500 | $0.00 |
| 2026-03-13 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Tax withholding | 1,521 | $8.62 |
| 2026-03-13 | D'Adamio Anthony | SVP & General Counsel | Option exercise | 8,886 | $0.00 |
| 2026-03-13 | D'Adamio Anthony | SVP & General Counsel | Tax withholding | 3,861 | $8.62 |
| 2026-03-13 | D'Adamio Anthony | SVP & General Counsel | Option exercise | 8,750 | $0.00 |
| 2026-03-13 | D'Adamio Anthony | SVP & General Counsel | Tax withholding | 3,802 | $8.62 |
| 2026-03-13 | Claypoole Robert E | President and CEO | Option exercise | 33,500 | $0.00 |
| 2026-03-13 | Claypoole Robert E | President and CEO | Tax withholding | 14,553 | $8.62 |
| 2026-03-11 | McMurry-Heath Michelle | Director | Open market sale | 12,000 | $8.79 |
| 2026-02-15 | Singleton Mark Leonard | SVP & CFO | Option exercise | 20,153 | $0.00 |
| 2026-02-15 | Singleton Mark Leonard | SVP & CFO | Tax withholding | 9,429 | $8.27 |
| 2026-02-15 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Option exercise | 4,375 | $0.00 |
| 2026-02-15 | CHURCH KATRINA J | SVP & Chief Compliance Officer | Tax withholding | 2,133 | $8.27 |
| 2026-02-15 | D'Adamio Anthony | SVP & General Counsel | Option exercise | 12,980 | $0.00 |
| 2026-02-15 | D'Adamio Anthony | SVP & General Counsel | Tax withholding | 6,327 | $8.27 |
| 2026-01-09 | Claypoole Robert E | President and CEO | Option exercise | 93,750 | $0.00 |
| 2026-01-09 | Claypoole Robert E | President and CEO | Tax withholding | 41,717 | $8.03 |
| 2025-12-04 | NOHRA GUY P | Director | Open market sale | 10,000 | $7.57 |
| 2025-11-07 | McMurry-Heath Michelle | Director | Open market sale | 17,701 | $7.42 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:13 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-05 | 10-Q | 2026-06-27 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
| 2026-06-04 | 4 | 2026-06-02 | View on SEC.gov → |
Recent news
Headlines about BVS (Bioventus Inc. Class A). Links open the publisher — we don’t host full articles.
-
Is Bravura Solutions (ASX:BVS) Still Cheap After Its Rerating?
Kalkine Media · 2026-10-21 -
What Did Bravura Solutions (ASX:BVS) Report for FY26, and What Is in Its Dividend and Capital Plans?
Kalkine · 2026-10-21 -
Bravura Solutions (ASX:BVS) Shares Up About 7% in a Year: What Did Its FY26 Result and AIM Listing Add?
Kalkine · 2026-10-20 -
What Capital Management Steps Did Bravura Solutions Ltd (ASX:BVS) Announce With Its FY26 Results?
Kalkine · 2026-10-19 -
BVS Q2 2026 Earnings: Bioventus Edges Past EPS Estimate as Shares Gain 2.3% - Earnings Quality Score
https://www.dars.gov.et/ · 2026-10-16 -
Liquidity Mapping Around (BVS) Price Events
Stock Traders Daily · 2026-10-15 -
Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale
Seeking Alpha · 2026-09-21 -
Are Medical Stocks Lagging Bioventus (BVS) This Year?
Yahoo Finance · 2026-08-24
No headlines in this category right now — try “All”.